Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A second human papillomavirus (HPV) recombi-nant vaccine has been approved by the FDA.

Pharmacology Update: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)